may 2008 the bi-monthly newsletter news€¦ · ‘napoleon’s buttons’ wherein the authors le...
TRANSCRIPT
Flying highFlying highFlying highFlying high This editorial starts at 33,000 feet. On the plane from Dubai to Munich I am recalling five days, rich in events. Being president of ESCP gives some privilege. To assist at the conference called ‘DUPHAT’ for example (DUPHAT = Dubai Pharmaceutical Technology conference).
This conference offers a magnificent program with speakers from all over the world. Meeting them in Dubai means exchanging views in a special environment. At the same time cultures are mixing and, despite the formal differences, communicating without too much difficulty. As an invited speaker at the conference I did not just have to deliver my plenary lecture, I also got involved in quite a lot of activities.
Students at the five colleges of pharmacy of the United Arab Emirates tried to take the lead with their poster presentations and oral communications.
We were kindly invited to score heir merits. They enthusiastically explained their findings, mostly taken from the literature but sometimes also emerging from interesting interventional research. The last day of the conference the trophies were distributed, the whole conference hall crowded with supporters of the student teams involved. An original project on the educational needs of practicing pharmacists and the way these needs can be met in a continuous education program was granted with a first place in the competition.
Plenary lectures deal with subjects strongly related to clinical pharmacy. I was most intrigued by the lecture of Pete Vanderveen who could collect millions of funding for the Los Angeles Area Safety Net Clinics. The USC Community Pharmacy Group is a specialty area of faculty practice in the Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy at the University of Southern California (USC). The group cares for and educates underserved populations in some of Los Angeles’ poorest areas. To that end it has developed and implemented a variety of programs that serve as role models for demonstrating pharmacist value in improving access to greatly needed services. The activities aim at improving health outcomes among the neediest populations in Los Angeles county. The work Pete Vanderveen started is a nice example of caring in a large sense. Students and patients are pleased with this form of holistic caring for the human condition.
Taking Dubai as a venue, Dr. Hussain wants the western world to meet with the Middle East. This is not only the case for the scientific event. Dubai is a melting pot of races and cultures: citizens of the United Arab Emirates, working force from
Sri Lanka, Pakistan and Ethiopia, business people trying to find stable values for their money (160 billion US$ is actually invested in building projects), tourists amazed about the changing environment, dredging companies creating islands like a palm tree and scientists gathering at the conference centre.
Mid March the climate is enjoyable: temperatures around 22°C during daytime, a cooling wind in the evening, ideal circumstances to welcome the attendants. Duphat is a unique event. On behalf of ESCP I send to Dr. Hussain my congratulations with the high conference level and my sincere thanks for his hospitality and his invitation.
Going fastGoing fastGoing fastGoing fast The European Association of Hospital Pharmacists (EAHP) chose the pretty town of Maastricht on the borders of the Meuse river as the venue for their annual conference with the theme ‘Hospital Pharmacists: Added Value for Health’.
The presidents of EAHP and ESCP send mutual invitations for the respective annual meetings. Invited by the EAHP president Jacqueline Surugue, it was my turn to take a train ride, across the border with the Netherlands.
During the opening ceremony Roberto Frontini of EAHP was conducting more than 80 musicians on the stage. Bert Leufkens (who was also a plenary speaker in Dubai) delivered the main keynote lecture on ‘The role and added value of the hospital pharmacist in health care: beyond Napoleon’s Buttons’, referring to the title of a book ‘Napoleon’s Buttons’ wherein the authors Le Conteur and Burreson (2003)
To be continued p.2
The bi-monthly newsletter of the European Society
of Clinical Pharmacy News
E u r o p e a n S o c i e t y o f C l i n i c a l P h a r m a c y The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by society.society.society.society.
ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
A Few Words
1
Open and disarmedOpen and disarmedOpen and disarmedOpen and disarmed
ContentsContentsContentsContents : A Few words 1 ESCP life 2 Articles & Reports 4 Announcements 8
ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
ESCP life
2
are telling stories about the 17 molecules that changed history. Bert dealt with the constant need for pharmaceutical innovation and the role the (hospital) pharmacists can play in the development of new drugs, from trials to their approval and afterwards in tak ing r espons ib i l i t y in pharmacovigilance activities.
The two day EAHP congress was well structured, plenary lectures alternating with parallel seminars. During a nice dinner in the city I enjoyed inspiring company. Actually EAHP and ESCP are further looking for opportunities to
collaborate on international meetings and conferences. Thank you Jacqueline and Roberto for being so cooperative. Frank Jorgensen as vice-president, and myself, we took the opportunity during the Congress in Maastricht to promote the ESCP Oncology Workshop in Leuven and the fall symposium in Dubrovnik. We are heading to these two events very fast as was the train that brought me back to Leuven.
Taking a deep breathTaking a deep breathTaking a deep breathTaking a deep breath
Fast train riding is what I experience during a normal working day. Half an hour biking to the railway station and a one hour train ride separates my home from Leuven University. I leave early in the morning and returning home comes only after the sunset.
During spring time the air is condensed at evening time. I can smell the typical odors of the changing season when I bike across the country side. The smell of wet grass, kept over the cold season and uncovered for feeding cattle, mixes with the aroma of flowering Prunus laurocerasus.
Taking a deep breath helps evaporate all the concerns of the day. By half an hour biking and respiring the balance is restored between tension and detention.
Being disarmedBeing disarmedBeing disarmedBeing disarmed
The past Easter holiday we had the opportunity to spend a few days at the Belgian coast with our two grandchildren. It was a nice experience for both parties. By communicating with young children I became again aware of another world where small things are very important. Caring for children has a generic value. As in the general process of com-municating, attention and patience are essential. At the same time there is a need for creativity. Adults are disarmed when children are passing their message to adults. Communicating is a never ending story. We have to remain humbly attentive for what comes to us. This is also true for ESCP. We should not be afraid of being disarmed, because only then we can really make the approach to others: other members within ESCP, but also other organizations within the clinical pharmacy network. The international meetings to come give us splendid opportunities to ensure the attractiveness of ESCP by being receptive from our side, by opening our eyes and ears for the messages spread. We are looking forward to meeting you!
Gert LaekemanGert LaekemanGert LaekemanGert Laekeman, Your president
Cecilia B Bernsten is a registered phar-macist in Sweden and an Associate Professor at Uppsala University within the Department of Public Health and Caring Sciences. She is currently employed as a re-searcher at Apoteket AB, and is the President of the Swedish Pharmaceut-cal Association. Her background is in Social Pharmacy and in her research she has focused on usage of medicines- how it is done, why there are differences, what affects the usage. Cecilia is especially intrigued by the professional and organizational influ-ence on drug usage. Currently she is active in research programmes within the area of Pharmaceutical Care, both
how it is being performed as well as how it is perceived by patients and pharmacists. Clinical pharmacy is developing in Sweden right now along with the major changes that are taking place in the pharmacy sector as a whole. Cecilia spends a lot of her professional time to promote clinical pharmacy and to try to make pharmacy in Sweden be-come an integrated part of perception of health care. Cecilia Bernsten: "What is the purpose of pharmacy is a question I constantly ask. My answer is of course to help people get well or free of symptoms, and to prevent ill health. It is thus evi-dent that clinical pharmacy, as I per-ceive it, is the very core of pharmacy."
Who’s Who Cecilia BernstenWho’s Who Cecilia BernstenWho’s Who Cecilia BernstenWho’s Who Cecilia Bernsten
A few words A few words A few words A few words (continued)(continued)(continued)(continued)
ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
ESCP life
3
New ESCP Award Category: Fellowship (FESCP)New ESCP Award Category: Fellowship (FESCP)New ESCP Award Category: Fellowship (FESCP)New ESCP Award Category: Fellowship (FESCP)
Although called ‘Publication commit-tee’, this enthusiastic group of people in reality coordinates all communica-tions means within the society, from website to reports. External communi-cation is the responsibility of the Gen-eral Committee, although part of that work also has been delegated to this committee. Let me give some examples of the work of the Publication Committee. In the last committee meeting we discussed the way that conference abstracts are currently submitted and rated. The whole submission process falls under the responsibility of the publication committee. Ideally we would need a specialised search en-gine on the website to search through the abstract archives, and there possi-bly is money to install such an engine. We also proudly presented the latest version (version 5) of the Guidelines for Successful Presentations, printed in 2007 with the help of Pfizer France.
These Guidelines can now be avail-able to members and non-members at every possible occasion. Of course we discussed this Newsletter and its con-version into electronic format. Together with the General Committee, the members of the publication com-mittee also brainstormed about the future of the Society, and especially the role of Special Interest Groups. We also spoke about the role of Phar-macy World & Science (PWS), the ‘house’ scientific journal of the ESCP and also of the English clinical phar-macy organisation, UKCPA, and the Dutch pharmacist association KNMP. Members of ESCP can access the electronic version of this journal and its archives through the ESCP website, after login. The scientific abstracts of ESCP congresses and workshops are published in this journal, that is run by Springer Science & Business Media. As for the presence of the society on the World Wide Web, this also is dis-
cussed regularly in the Publication Committee. Especially topics like host-ing and content management are of great concern, because they are so important for the ESCP in these times of change. Although the publication committee has not yet received permission to change its name to Communication Committee’, this hopefully will come soon. But that will certainly not change the scope of the interesting work that the committee does! The current members of the commit-tee are Lillian Azzopardi (Malta), Johnny Beney (Switzerland), Erik Ger-brands (Netherlands), Jacqueline Grassin (France), Marie Caroline Hus-son (France), Louise Mallet (Canada, secretary), Jean Baptiste Rey (France), Daniele Scala (Italy), and under-signed.
Foppe van MilFoppe van MilFoppe van MilFoppe van Mil Chairman Publication Committee
The ESCP publication committeeThe ESCP publication committeeThe ESCP publication committeeThe ESCP publication committee
The GC of the ESCP is happy to an-nounce a new award category i.e., Fellowship (FESCP). Fellowship is awarded in recognition of continued excellence in clinical pharmacy prac-tice and/or research. Nominees must have been a full member of ESCP for at least 5 years; must have been in practice for at least 5 years since receipt of their highest professional pharmacy degree; and must have made a sustained contribution to ESCP through activities such as pres-entation at conferences/symposia/meetings; service to ESCP commit-tees, SIGs, or publications; or elec-tion as an officer.
Please find the detailed criteria for nominations for ESCP Fellow candi-dates as follows:
Description/CriteriaDescription/CriteriaDescription/CriteriaDescription/Criteria 1. 1. 1. 1. Fellowship is awarded in recogni-
tion of continued excellence in clinical pharmacy practice and/or research.
2. 2. 2. 2. Nominees must have been a full member of ESCP for at least 5 years; must have been in practice for at least 5 years since receipt of their highest professional phar-macy degree; and must have made a sustained contribution to ESCP through activities such as
presentation at conferences/symposia/meetings; service to ESCP committees, SIGs, or publi-cations; or election as an officer.
3. 3. 3. 3. Qualifying nominations for ESCP Fellow candidates must be cast by two Full Members or any Fel-low or any RESP chair.
4. 4. 4. 4. The ESCP GC decides on the nomination by a majority of votes.
5. 5. 5. 5. The successful candidate(s) will be recognized during the open-ing ceremony of ESCP fall con-ferences and announced in ESCP News.
6. 6. 6. 6. A list of fellows will be made avail-able at the ESCP homepage.
7. 7. 7. 7. Travel costs of the successful candidate(s) to attend the awarding ceremony shall not be reimbursed by ESCP.
8. 8. 8. 8. The successful candidate receives a plaque in recognition and may use the designation "FESCP".
9. 9. 9. 9. An ESCP Fellow, who, subse-quent to receiving the award, ceases to be an ESCP Individual Member, may not continue to use the designation FESCP.
10. 10. 10. 10. Unsuccessful candidates may be re-nominated, provided all crite-ria are still met at the time of re-nomination.
11. 11. 11. 11. Nominations should be submit-ted to the ESCP president before the 31 March of the year in which the award will be pre-sented, and should contain the following information: a) Curriculum Vitae of the can-
didate (in English, not ex-ceeding two A4/letter pages, sent by e-mail);
b) A statement of the reasons why the candidate has been nominated (in English, not exceeding two A4/letter pages, sent by e-mail), utiliz-ing the following headings: I. Continued excellence in clinical pharmacy practice and/or research (including a list of - selected/most re-cent - peer-reviewed publi-cations in the field of clinical pharmacy) II. Contribution to the ad-vancement of Clinical Phar-macy (preferable in Europe) III. Services to ESCP
c) Name, address, e-mail, fax and telephone number of the nominee.
Martin SchulzMartin SchulzMartin SchulzMartin Schulz GC member for Germany
Glossary of Scientific termsGlossary of Scientific termsGlossary of Scientific termsGlossary of Scientific terms ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
Articles & Reports
4
AAAA Absolute risk (AR) Absolute risk (AR) Absolute risk (AR) Absolute risk (AR) The probability that an individual will experience the specified outcome during a specified period. It lies in the range 0 to 1, or is expressed as a percentage. In contrast to common usage, the word "risk" may refer to adverse events (such as myocardial infarction) or desirable events (such as cure). ….
BBBB Block randomisation Block randomisation Block randomisation Block randomisation Randomisation by a pattern to pro-duce the required number of people in each group. ….
OOOO Odds ratio Odds ratio Odds ratio Odds ratio The odds of an event happening in the experimental group divided by the odds of an event happening in the control group. The closer the OR is to 1, the smaller the difference in effect between the experi-mental intervention and the control inter-vention. If the OR is greater (or less) than 1, then the effects of the treatment are more (or less) than those of the control treatment. Note that the effects being measured may be adverse (e.g. death or disability) or desirable (e.g. survival). When events are rare, the OR is analogous to the relative risk (RR), but as event rates in-crease the OR and RR diverge. ….
WWWW Weighted mean difference (WMD)Weighted mean difference (WMD)Weighted mean difference (WMD)Weighted mean difference (WMD) A measure of effect size used when outcomes are continuous (such as symptom scores or height) rather than dichotomous (such as death or myo-cardial infarction). The mean differ-ences in outcome between the groups being studied are weighted to account for different sample sizes and differing precision between studies. The WMD is an absolute figure and so takes the units of the original outcome measure. A continuous outcome measure, simi-lar to standardised mean differences but based on one scale so in the real units of that scale. ….
Few examples for the glossaryFew examples for the glossaryFew examples for the glossaryFew examples for the glossary
Pharmacy World & Science, Pharmacy World & Science, Pharmacy World & Science, Pharmacy World & Science, the scientific journal of ESCPthe scientific journal of ESCPthe scientific journal of ESCPthe scientific journal of ESCP
Pharmacy World and Science is doing well. The journal is receiving an in-creasing number of submissions which has resulted in an increase in the number of reviewers involved with the peer-review process. The down-side is that, in order to maintain stan-dards, a significant number of papers is being rejected.
A propos, with the Internet being the publishing platform of the future, the official publication date is now the date that the article appears in the Online First section of PWS on SpringerLink: http://www.springerlink.com/content/1573-739X/. When referencing, the DOI (Digital Object Identifier) should then be used. For example: Jaehde U, Liekweg A, Simons A, and Westfeld AE. Minimising treatment-associated risks in systemic cancer
therapy. Pharmacy World and Science 2007: DOI 10.1007/s11096-007-9157-4.
To keep abreast of this article-by-article online publication style, all you need to do is subscribe to the RSS (Really Simple Syndication) feed. A feed, also known as RSS feed, XML feed, syndicated content, or web feed, is frequently updated content pub-lished by a website.
Simply click on the RSS icon on the PWS pages on SpringerLink. Finally, we should mention that PWS last year has been awarded the honor-ary title of “Ambassador of Pharmacy” by the Polish publisher of “Czasopismo Aptekarskie”, a journal affiliated with the Polish Pharmacist Association.
Foppe van MilFoppe van MilFoppe van MilFoppe van Mil Editor-in-Chief, PWS
The Glossary provides assistance to all health care providers on the most utilized medical, scientific and techno-logical terms.
Europe includes a wide range of coun-tries, languages and culture. Thus, the same word does not mean the same thing for each European pharmacist. In this context, The Education and Training Committee launched the pro-ject of glossary in 2006 to assist Clini-cial Pharmacists in their practice.
The aim The aim The aim The aim of this glossary is to aid in the development of more standardized and established terminology for Clini-cal Pharmacy, facilitate the communi-cation across different stakeholders, and ultimately contribute to higher-quality Health care system.
How does it work?How does it work?How does it work?How does it work? Definitions are organized by alphabeti-cal order.
The Glossary is intended to be regu-larly updated and implemented. The initial letters are links to the words that start with them. Click on the letter you want to visualize all the words starting with that letter. To perform an automatic research of a word in the glossary, digit the word in the text box and click on the SEARCH to visualize the definition. The Glossary is not intended to be a comprehensive tool including all medi-cal terms but has a strong ambition that is to become a useful support also for clinical pharmacists working in this area and for users who occasion-ally encounter unusual terminology
often hard to understand on their medical status.
What you need to do?What you need to do?What you need to do?What you need to do? We encourage you to send us re-marks, comments that will be useful to improve this document. Please send suggestions and contributions to Dr. Anna Carollo with subject: glossary. We have created a dedicated email box ([email protected]).
We would like tot thank Dr. Annalisa Cam-pori, Dr. Katrin Schuessel and the ESCP Education and Training Committee, for their contribution for the development of this project.
Anna CarolloAnna CarolloAnna CarolloAnna Carollo Glossary project Coordinator
André RieutordAndré RieutordAndré RieutordAndré Rieutord Chair of Education & Training Committee
ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
Articles & Reports
5
STABILIS onlineSTABILIS onlineSTABILIS onlineSTABILIS online !!!!
The free database STABILISSTABILISSTABILISSTABILIS on stabil-ity and compatibility of injectable drugs is now available online at the address www.infostab.com . This database has been compiled in an international language based on pictograms (definitions in 24 lan-guages are provided for all the picto-grams). It was first created in 2001 and available as a CDROM since the third edition in 2006. Currently, the database contains a series of 374 Monographs. The following information is given for each drug:
- trade names in different countries, - stability in simple solution, - stability in admixtures, - factors affecting stability, - incompatibilities, - routes of administration, - relevant references. It contains also many summary lists like: - list of drugs incompatible with various solvents (sodium chloride 0.9%, dex-trose 5% …); - list of drugs stable in various contain-ers (PVC, EVA …); - list of drug that can provoke leaching of plasticizers.
Important new functions have been added into the online version like : - a pdf file which can be created for each monograph; - a search function for incompatibilities - a general search function; - link to abstracts or articles of the bibliographic references; - immediate translation of the picto-grams by the mouse; - new summary lists.
Jean VigneronJean VigneronJean VigneronJean Vigneron Président of INFOSTAB Association
11, rue Jacques Gruber 54180 Heillecourt - FRANCE
Home pageHome pageHome pageHome page
List of drList of drList of drList of drugsugsugsugs
Example of monographyExample of monographyExample of monographyExample of monography
The clinical pharmacist The clinical pharmacist The clinical pharmacist The clinical pharmacist in a bone marrow Transplantation Unitin a bone marrow Transplantation Unitin a bone marrow Transplantation Unitin a bone marrow Transplantation Unit
Our Egyptian colleague Dalia Abro Zahra would like to have some detailed information on the exact activities of a clinical pharmacist at a bone marrow transplantation unit.
If you think you can be of help, please contact her at [email protected].
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2008
February 2008
February 2008
February 2008 �� �� Number 138
Number 138
Number 138
Number 138 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
Articles & Reports
6
Teaching method for sharing practice and innovation Teaching method for sharing practice and innovation Teaching method for sharing practice and innovation Teaching method for sharing practice and innovation Education and Training SIGEducation and Training SIGEducation and Training SIGEducation and Training SIG
Better patient care is the goal of every healthcare provider in the world whether services are delivered by national or private organisations. Many organisations now recognise that pharmacists have a key role to support patient safety and influence organisational development and service re-design through proactive behaviour at senior management level. Integrated teamwork at this multidisciplinary level requires its own knowledge and skills including communication skills to ensure the pharmacy team have a clear vision of healthcare providers’ targets and priorities. Clinical pharmacists must be aware of the strategic planning process and contribute to the planning of clinical service re-design taking into account professional change such as the opportunities for non-medical prescribing. Among other roles and responsibilities, many pharmacists have leadership responsibility for the development, implementation, monitoring and review of prescribing guidelines and policies.
InterInterInterInter----professional learningprofessional learningprofessional learningprofessional learning The aim of the Education and Training SIG is to support members who have a role in the education and development of clinical pharmacists who deliver pharmaceutical care to individual patients. Members of the SIG are invited to feedback if they perceive a need to develop workshops or courses in developing advanced practitioners with more strategic responsibilities. Inter-professional learning is being
promoted to improve collaboration among professionals and as a result, improve patient care. Should we also be exploring inter-professional learning within ESCP?
Several Education and Training SIG clinical teaching courses and workshops have explored the use of different teaching methods including use of real-life patients to support development of clinical skills. Group discuss ions have fac i l i ta ted consideration of transfer of these teaching methods to individual members’ own practice. The optimum method of sharing these experiences requires exploration. Although website networking is the most obvious, members enjoy face-to-face discussion at conferences. It would be healthy if ESCP members could feedback preferred methods for sharing teaching practice and innovation to the SIG Education and Training.
Development of clinical pharmacy Development of clinical pharmacy Development of clinical pharmacy Development of clinical pharmacy teacher practitionersteacher practitionersteacher practitionersteacher practitioners Although we accept that clinical pharmacy practice varies depending on the stage of service development and the patient care setting, there is a requirement for core transferable skills. As teachers we should be aware of the stages of learning and preferred learning styles of our trainees as we design activities to support development of these core skills. Learning needs can be identified and learning objectives agreed to move the trainee to a situation where they are consciously
competent. The learning methods agreed may be dependent on the learners preferred style of learning (activist, reflector, theorist and pragmatist). Problem based learning using case studies to stimulate self-directed learning of knowledge and application of that knowledge to the patient is an established learning method in clinical pharmacy. Dependent learners resent freedom to learn and prefer to be tutored. Self-directed learners resent an authoritarian teacher and prefer to be autonomous but to receive regular feedback, this can provide the best kind of learning. As clinical pharmacy teachers we are skilled in our own practice and usually work at the leve l o f unconsc ious l y competent. In providing feedback, we need to take a step back to help our learners, the teacher must also be consciously competent. With practice, the trainee becomes unconsciously competent. As trainees become familiar with the learning cycle they become more autonomous and take control of their own learning in preparation for life-long learning through the continuous professional development model. Within ESCP we need to seek more opportunities to further explore the application of these educational principles in the development of clinical pharmacy practitioners. I look forward to hearing your ideas and suggestions.
Moira KinnearMoira KinnearMoira KinnearMoira Kinnear Education and Training SIG
Co-ordinator
The SIG geriatrics is aging well. Over the past few years, the SIG group has been present at ESCP meeting. Work-shops have been conducted on differ-ent themes that addressed issues related to the care of elderly patients: such as How to manage drug interac-tions in the elderly; Osteoporosis: a breaking disease; Continuity of care in the elderly. A workshop on Care of the elderly pa-tients with cancer will be given in Leu-ven in May 2008 with a geriatrician who specializes in oncology. She will bring a geriatric aspect to the care of this special population. Our ״geriatric” group has 97 active members. An e-mail distribution list has been created and each month a
message is sent to members. Perti-nent articles related to the care of geriatrics are being forwarded to the members. Clinical vignettes of prob-lems related to clinical cases are pre-sented to the members for their com-ments and suggestions on how they would solve the problems. Here is an example of “brain-food” that was sent to the members in March: A 75-year-old patient was admitted to the geriatric unit with the following medications: Carbamazepine 400 mg 2 x/day; Coumadin 10 mg 1 x/day; Quetiapine 25 mg 2 x/day; Clonazepam 1 mg 3 x/day; Sotalol 80 mg 1 x/d; Valproic acid 125 mg 2 x/day (started on Feb 8, 2008)
On admission: INR at 1.6: Car-bamazepine level at 28 umol/L These medications had been pre-scribed for the past year; he was get-ting his medications monthly from his community pharmacist. The patient was not able to report how he was managing at home. His wife was not available to help. One day prior to admission, the patient became very paranoid, confused, agi-tated- he got out of the car where he was travelling with his son- went into a store and told the clerk that his son wanted to kill him.
Louise MalletLouise MalletLouise MalletLouise Mallet SIG co-ordinator
Header for SIG geriatrics sectionHeader for SIG geriatrics sectionHeader for SIG geriatrics sectionHeader for SIG geriatrics section Greeting from the SIG geriatricsGreeting from the SIG geriatricsGreeting from the SIG geriatricsGreeting from the SIG geriatrics
Scientific programmeScientific programmeScientific programmeScientific programme Wednesday 22 October 2008Wednesday 22 October 2008Wednesday 22 October 2008Wednesday 22 October 2008
Balancing costs and effectivenessBalancing costs and effectivenessBalancing costs and effectivenessBalancing costs and effectiveness
• The balancing act and therapeutic costs
• Clinical evidence in therapeutic innovations
• Economic evaluation of pharmacy practice
Pharmacotherapy Update I: NeurologyPharmacotherapy Update I: NeurologyPharmacotherapy Update I: NeurologyPharmacotherapy Update I: Neurology Thursday 23 October 2008Thursday 23 October 2008Thursday 23 October 2008Thursday 23 October 2008
Pharmacotherapy Update II: Cardiovascular Pharmacotherapy Update II: Cardiovascular Pharmacotherapy Update II: Cardiovascular Pharmacotherapy Update II: Cardiovascular risk managementrisk managementrisk managementrisk management
Translating evidence into practiceTranslating evidence into practiceTranslating evidence into practiceTranslating evidence into practice
• The diffusion of innovations: which techno-logy to choose
• Translating clinical trials into clinical practice
• New pharmaceutical care models: how to change clinical practice?
Pharmacotherapy Update III: HIVPharmacotherapy Update III: HIVPharmacotherapy Update III: HIVPharmacotherapy Update III: HIV Friday 24 October 2008Friday 24 October 2008Friday 24 October 2008Friday 24 October 2008 Changing risks in patient safetyChanging risks in patient safetyChanging risks in patient safetyChanging risks in patient safety
• Skills required to prepare for the changing risks in medicine safety
• Professional implications of the shift to non-prescription medicines
• Systems of pharmaceutical care to address patient safety
Pharmacotherapy Update IV: Pharmacotherapy Update IV: Pharmacotherapy Update IV: Pharmacotherapy Update IV:
• Innovative drugs: how to evaluate the value-added of a new technology
Symposium PresidentSymposium PresidentSymposium PresidentSymposium President Maja Jakševa-Mikša, Croatia
Scientific committeeScientific committeeScientific committeeScientific committee
Lilian M. Azzopardi, Malta Marcel Bouvy, The Netherlands Vesna Bačić Vrca, Croatia Cecilia Bernsten, Sweden Jelena Filipović Grčić, Croatia Steve Hudson, United Kingdom Marie-Caroline Husson, France Sam Salek, United Kingdom Anthony Serracino-Inglott (Chair), Malta Foppe van Mil, The Netherlands Maurice Zarb-Adami, Malta
Organizing committeeOrganizing committeeOrganizing committeeOrganizing committee
Franciska Desplenter, Belgium Tihana Govorčinović, Croatia Jacqueline Grassin, France Aleksandra Grundler, Croatia Danijela Huml, Croatia Maja Jakševac Mikša (Chair), Croatia Iva Jankovic, Croatia Nikola Kujundžic, Croatia Georges Zelger, Switzerland
31 March 2008 Registration openRegistration openRegistration openRegistration open
31 March 2008
Abstract submission Abstract submission Abstract submission Abstract submission openopenopenopen
27 June 2008 Abstract submission Abstract submission Abstract submission Abstract submission
deadlinedeadlinedeadlinedeadline
1 September 2008 Early bird registration Early bird registration Early bird registration Early bird registration
deadlinedeadlinedeadlinedeadline
22 October 2008 Late registration Late registration Late registration Late registration
deadlinedeadlinedeadlinedeadline
To learnlearnlearnlearn more more more more about the
programme and register, visitvisitvisitvisit:
www.escpweb.org or mail
The 37th ESCP European Sym-The 37th ESCP European Sym-The 37th ESCP European Sym-The 37th ESCP European Sym-posium Clinical Pharmacyposium Clinical Pharmacyposium Clinical Pharmacyposium Clinical Pharmacy
Pharmaceutical Care Pharmaceutical Care Pharmaceutical Care Pharmaceutical Care Models & Therapeu-Models & Therapeu-Models & Therapeu-Models & Therapeu-tic Innovationstic Innovationstic Innovationstic Innovations
Dubrovnik, CROATIADubrovnik, CROATIADubrovnik, CROATIADubrovnik, CROATIA 22222222----24 October 200824 October 200824 October 200824 October 2008
37373737thththth ESCP, Dubrovnik ESCP, Dubrovnik ESCP, Dubrovnik ESCP, Dubrovnik 22222222----24 October 200824 October 200824 October 200824 October 2008
! ! ! ! ! SUBMIT YOUR POSTERS ! ! ! ! !! ! ! ! ! SUBMIT YOUR POSTERS ! ! ! ! !! ! ! ! ! SUBMIT YOUR POSTERS ! ! ! ! !! ! ! ! ! SUBMIT YOUR POSTERS ! ! ! ! !
Abstract submission is open from 31 March 2008
Deadline is 27 June 2008, Midnight, CET27 June 2008, Midnight, CET27 June 2008, Midnight, CET27 June 2008, Midnight, CET
http://abstract.mci-group.com/cgi-bin/mc/
startabs.pl?ID=ESCP2008
2008200820082008
26262626----28 May28 May28 May28 May
Leuven (Belgium)
Workshop on Oncology
22222222----24 October24 October24 October24 October
Dubrovnik (Croatia)
37th ESCP European Symposium on Clinical Pharmacy
2009200920092009
23232323----25 April25 April25 April25 April
Orlando (USA)
Joint Meeting ESCP—ACCP
OctoberOctoberOctoberOctober
Switzerland
38th ESCP European Symposium on Clinical Pharmacy
For Your DiaryFor Your DiaryFor Your DiaryFor Your Diary
ESSSSCP European Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical Pharmacy
ESCP News ESCP News ESCP News ESCP News is published by ESCP Editor: Marie Caroline Husson (France) Co-ordinator: Lilian M. Azzopardi (Malta) Page make-up: Corinne Tollier (France)
The contents of this publication are compiled in good faith. The publisher accepts no responsibility for omissions or errors.
ESCP International OfficeESCP International OfficeESCP International OfficeESCP International Office It Krúswâld Pharmacy—Voorstraat 13 NL-9285 NM Buitenpost—The Netherlands Tel: +31-645 915 831 Fax : +31 511 543 660 E-mail: [email protected] www.escpweb.org Deadline for the submission of material: for issue number 140 is 15 June 2008 ; for issue number 141 is 15 October 2008.
ESCP News
ESCP News
ESCP News
ESCP News �� �� May 2008
May 2008
May 2008
May 2008 �� �� Number 139
Number 139
Number 139
Number 139 �� �� I I I ISSN 1353
SSN 1353
SSN 1353
SSN 1353-- -- 0321
0321
0321
0321
Announcements
8
From July 1st 2007 on the International Office of ESCP was transferred From July 1st 2007 on the International Office of ESCP was transferred From July 1st 2007 on the International Office of ESCP was transferred From July 1st 2007 on the International Office of ESCP was transferred from Brussels to Buitenpost in The Netherlands:from Brussels to Buitenpost in The Netherlands:from Brussels to Buitenpost in The Netherlands:from Brussels to Buitenpost in The Netherlands:
ESCP International OfficeESCP International OfficeESCP International OfficeESCP International Office "It Krúswâld" Pharmacy"It Krúswâld" Pharmacy"It Krúswâld" Pharmacy"It Krúswâld" Pharmacy————Voorstraat 13Voorstraat 13Voorstraat 13Voorstraat 13————NLNLNLNL----9285 NM Buitenpost9285 NM Buitenpost9285 NM Buitenpost9285 NM Buitenpost
The NetherlandsThe NetherlandsThe NetherlandsThe Netherlands Email: [email protected]: [email protected]: [email protected]: [email protected]
Tel: +31 645 915 831Tel: +31 645 915 831Tel: +31 645 915 831Tel: +31 645 915 831————Fax: +31 511 543 660Fax: +31 511 543 660Fax: +31 511 543 660Fax: +31 511 543 660
www.escpweb.orgwww.escpweb.orgwww.escpweb.orgwww.escpweb.org
New membersNew membersNew membersNew members
France:France:France:France: .................................. Mireille Jouannet ....................Clermont-Ferrand .................................. Céline Eiden............................Montpellier .................................. Charles Esquirol......................Paris .................................. Patricia Hubert........................Saint-Denis .................................. Hervé Javelot ..........................Brumath Belgium:Belgium:Belgium:Belgium: .................................. Eva De Baere ..........................Jette .................................. Tinne Leysen...........................Brussel Bosnia and Herzegovina:Bosnia and Herzegovina:Bosnia and Herzegovina:Bosnia and Herzegovina: .................................. Tijana Marinkovic ...................Banja Luka Sweden:Sweden:Sweden:Sweden: .................................. Petra Laveno...........................Göteborg Switzerland:Switzerland:Switzerland:Switzerland: .................................. Chantal Csajka........................Lausanne